When you look at a hydrogen and methane breath test report, it is easy to focus on the gas values and the shape of the curve. But a question sits underneath every interpretation and rarely appears anywhere on the page: how sure are we that this is a true breath sample?
CO₂ correction is how a laboratory answers it. It is the most overlooked safeguard in breath testing, and the one that decides whether the numbers on the report describe the patient’s gut or describe how they exhaled.
The short answer
Every breath sample is a mixture of alveolar air from deep in the lung, which carries the hydrogen and methane signal, and dead space air from the mouth and upper airway, which dilutes it. CO₂ concentration is relatively consistent in alveolar air, so measuring CO₂ alongside hydrogen and methane reveals how much of the sample is actually alveolar. A low CO₂ reading means the patient did not exhale deeply enough and the gas values are artificially low. CDI measures CO₂ on every sample and treats any sample with a correction factor above 2.50 as invalid.
Breath Testing Done Right — a full chapter on CO₂ correction, plus sample stability, protocol, and program design.
What CO₂ correction actually does
CO₂ correction adjusts the raw hydrogen and methane readings in a breath sample so they reflect alveolar gas concentrations, accounting for dilution that occurs as the sample passes through the mouth and upper airway.
That adjustment does three things at once:
- Diagnostic accuracy. Corrected values describe what is happening in the gut rather than how completely the patient exhaled.
- Consistency. Samples can be compared against one another, and against the same patient over time, without exhalation technique introducing drift.
- Protection against false lows. Dilution by ambient air pushes hydrogen and methane readings downward. Without correction, that looks like a negative result.
What is in a breath sample
Every exhaled sample is a mixture of two things. Alveolar air comes from deep in the lung and carries the hydrogen and methane produced by fermentation in the gut. Dead space air sits in the mouth, trachea, and upper airways, and reflects nothing about the gut at all. It simply dilutes the sample.
If a patient does not exhale fully, the proportions shift. More dead space, less alveolar air, and hydrogen and methane readings that come in lower than they should.
CO₂ is the internal quality-control marker that makes this visible. Alveolar air carries a relatively consistent CO₂ concentration, so if the measured CO₂ in a sample is low, it is a direct signal that the patient did not provide a deep, complete exhalation.
What each breath actually contains
The same test, two very different samples
A deep, complete exhalation. Alveolar air dominates, CO₂ falls in range, and the gas values describe the gut.
A shallow or rushed breath. Dead space dominates, the hydrogen and methane signal is diluted, and the result reads low for a reason that has nothing to do with the patient’s gut.
Why it matters in everyday GI practice
In a busy GI group, not every patient follows collection instructions perfectly. Some are anxious and blow too quickly. Some never form a proper seal. Some have comorbid pulmonary conditions that make a deep, consistent exhalation genuinely difficult.
None of that is a failure of the patient or the practice. It is simply what happens at scale. The question is whether your lab detects it.
Without CO₂ correction, you may never see those problems reflected in the report at all.
What goes wrong, in order
Three failures, each one quieter than the last
A patient with genuine overgrowth or malabsorption appears negative, because the sample was diluted rather than because the finding was absent.
Symptoms persist despite the negative result, so care moves to empiric therapy, a repeat test, or more invasive diagnostics — with no one aware the first sample was flawed.
After a few such cases, clinicians quietly discount breath testing altogether. Ordering drops off without anyone ever deciding to stop.
What “done right” looks like
In a robust breath testing program, CO₂ is treated as a built-in guardrail rather than an optional extra. Four things separate that from a claim.
The standard
Four requirements, not one assurance
- Every sample is assessed for CO₂. Not a subset, not on request, not only when a result looks odd.
- There is a defined response to low CO₂. A published threshold above which a sample is non-interpretable, or a validated protocol for interpreting with explicit caution.
- Quality signals reach the interpreting clinician. Visible on the report, not buried in back-end analytics the practice never sees.
- Patient instructions support good technique. Collection guidance built around a deep, complete exhalation, so fewer samples fail in the first place.
Five questions to ask your lab
CO₂ correction is invisible when it is handled well, which makes it hard to evaluate from outside. These five questions surface the difference between a control and a claim.
Take these to your next vendor conversation
Questions for your lab
Any lab running CO₂ as a real control will have these answers ready.
- Do you measure CO₂ for each breath sample? If not, how do you detect under-collection?
- How do you use CO₂ values in your quality-control process — flags, rejections, or adjustments?
- How are CO₂-related quality issues communicated on the report to the interpreting clinician?
- Have your CO₂ thresholds been validated in GI patient populations?
- What patient-facing materials support good exhalation technique at home?
A note on labs that do not publish a threshold
Question two is the one that separates programs. Measuring CO₂ and acting on CO₂ are different things, and a lab that cannot name the point at which it rejects a sample is describing a measurement rather than a control. That is not an argument against any particular provider. It is an argument for asking all five questions of whichever lab you use today, and expecting specifics rather than assurance.
The self-assessment covers CO₂ correction, sample stability, and guideline alignment in 10–15 minutes.
CDI’s CO₂ correction methodology
CDI measures CO₂ alongside hydrogen and methane on every sample, and applies a defined threshold rather than a judgment call. Here is the full process.
Collection
Patients ingest a fermentable substrate such as lactulose or glucose, and samples are collected into CDI’s proprietary tubes, which hold samples stable for up to two weeks across a wide temperature range. That stability window is what makes at-home collection viable without trading away data quality — the subject of our companion article on sample stability.
Measurement and correction
CO₂ is measured alongside hydrogen and methane for every sample. Proprietary algorithms then adjust the gas values to account for dilution by ambient air, so the reported figures reflect alveolar concentrations.
The threshold
Any sample with a correction factor above 2.50 is treated as invalid and excluded. This is the answer to question two above, and it is deliberately specific: a sample either clears the threshold or it does not.
Reporting
Reports show corrected hydrogen and methane values, so the quality check is part of what the interpreting clinician sees rather than something that happened out of view.
Quality parameters
What sits behind a CDI result
Sample treated as invalid and excluded.
CO₂ measured alongside H₂ and CH₄, not on a subset.
Across a wide tested temperature range.
The quality check is visible to the clinician.
FDA registered and CE marked kits.
Gas chromatography with CO₂ correction.
Beyond the analytics, MyGI Gateway centralizes breath testing data for ordering, registration, status, and results, and our provider resource center carries the patient-facing collection materials that reduce poor samples before they are ever mailed.
The counterpart to sample stability
CO₂ correction and sample stability solve two halves of one problem. CO₂ confirms the sample was collected properly in the first place. Stability safeguards ensure that sample is still trustworthy by the time it reaches the analyzer. A program needs both before a clinician can look at a curve and act on it.
There is an operational consequence too. A sample rejected for low CO₂ is a completed test that produced no usable data, which drags down return ratio exactly as an unreturned kit would — and sends a practice chasing patient reminders when the real fix is collection technique. Separating “never returned” from “returned but not interpretable” is what tells you which problem you actually have.
CO₂ correction will never show up as a bold number in your report header. It quietly underpins whether your hydrogen and methane curves can be trusted at all.
CO₂ correction FAQs
What is CO₂ correction in breath testing?
CO₂ correction adjusts the raw hydrogen and methane readings in a breath sample so they reflect alveolar gas concentrations, accounting for dilution as the sample passes through the mouth and upper airway. It makes results comparable across samples and over time, and prevents a diluted sample from reading as a falsely low result.
Why is CO₂ used as the quality marker?
Alveolar air carries a relatively consistent CO₂ concentration. Measuring CO₂ alongside hydrogen and methane therefore reveals how much of a given sample is genuinely alveolar air rather than dead space air from the mouth and upper airway. A low CO₂ reading is a direct signal that the exhalation was shallow or incomplete.
Can a breath test be falsely negative without CO₂ correction?
Yes. Dead space air dilutes the hydrogen and methane signal, so an incomplete exhalation pushes gas values lower than they should be. Without a CO₂ measurement, a patient with genuine bacterial or methanogen overgrowth can appear negative, and nothing on the report indicates that the sample was the problem.
What is alveolar air versus dead space air?
Alveolar air comes from deep in the lung and carries the hydrogen and methane produced by fermentation in the gut, which is the signal a breath test is measuring. Dead space air sits in the mouth, trachea, and upper airways, reflects nothing about the gut, and simply dilutes the sample. A good sample is mostly alveolar air.
What CO₂ correction factor does CDI use?
CDI measures CO₂ on every sample and treats any sample with a correction factor above 2.50 as invalid, excluding it rather than reporting it. Reports show the corrected hydrogen and methane values, so the quality check is visible to the interpreting clinician.
What should I ask a lab about CO₂ correction?
Five things: whether CO₂ is measured on every sample, how CO₂ values are used in quality control, how quality issues are communicated on the report, whether the thresholds have been validated in GI patient populations, and what patient-facing materials support good exhalation technique at home. The second question matters most, because measuring CO₂ and acting on it are different things.
How does CO₂ correction relate to sample stability?
They solve two halves of one problem. CO₂ correction confirms the sample was collected properly. Sample stability safeguards ensure it is still trustworthy by the time it reaches the analyzer. A breath testing program needs both before a clinician can confidently act on a curve.
Can a rejected sample look like a patient compliance problem?
Yes. A sample excluded for low CO₂ is a completed test that produced no usable data, so it lowers return ratio exactly as an unreturned kit would. A practice seeing a soft return ratio may add patient reminders when the real fix is collection technique. Separating never returned from returned but not interpretable reveals which problem you actually have.
Breath Testing Done Right
Trust the curve before you act on it
Forty-five pages on clinical integrity, protocol, operational performance, and economic yield — including full chapters on CO₂ correction and sample stability.
